Skip to main content

Dedalus France S. A. (MED.PA) Stock Price and Company Information, 2024

Dedalus France S. A.

MED.PA

Exchange: PA
Currency Euro
Fiscal Year End: December
Sector: Other
Industry: Other
Gic Sector: Materials
Gic Group: Materials
Gic Industry: Metals & Mining
Gic Sub Industry: Diversified Metals & Mining
Description: Dedalus France S.A. provides software solutions for healthcare businesses in France, Belgium, Japan, Algeria, Morocco, and internationally. The company offers Dx Care, a health information system that provides solutions in the areas of medical record, EMR, pathology record, nurse record, back office, secure message, planning, anesthesia, chemotherapy, operating room, decision tree, PMSI, billing, pharmacy-drug circuit, patient physiological data, mobility, bed management, reporting, emergency, and intensive care unit. It also operates Dx Image, a solution for exchanges between PACS, transfer of images, and search for a patient's radiology documents; and solutions for medical biology, anatomic pathology, and genetic laboratories. In addition, the company offers services, such as support and maintenance, hosting/managed services/ASP/software as a service, and training services. The company was formerly known as Medasys S.A. and changed its name to Dedalus France S.A. in March 2019. The company is based in Le Plessis Robinson, France. Dedalus France S.A. is a subsidiary of NOEMALIFE S.p.A.
Full Time Employees: 401
Updated On: 2023-08-27

Highlights

Market Capitalization: 37072860
Market Capitalization Mln: 37.07
PE Ratio: 9.16
Wall Street Target Price: 0.5